Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Phylogica Ltd.
DescriptionRetro-inverted peptides derived from sub-domains of natural proteins
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationShock / trauma
Indication DetailsTreat traumatic brain injury (TBI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today